Compare Glenmark Pharma with KOPRAN. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GLENMARK PHARMA vs KOPRAN. - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GLENMARK PHARMA KOPRAN. GLENMARK PHARMA/
KOPRAN.
 
P/E (TTM) x 17.7 16.8 105.0% View Chart
P/BV x 2.8 5.5 51.8% View Chart
Dividend Yield % 0.4 0.0 -  

Financials

 GLENMARK PHARMA   KOPRAN.
EQUITY SHARE DATA
    GLENMARK PHARMA
Mar-20
KOPRAN.
Mar-20
GLENMARK PHARMA/
KOPRAN.
5-Yr Chart
Click to enlarge
High Rs66046 1,431.0%   
Low Rs16816 1,040.2%   
Sales per share (Unadj.) Rs377.183.1 453.7%  
Earnings per share (Unadj.) Rs27.54.9 565.8%  
Cash flow per share (Unadj.) Rs42.37.1 597.7%  
Dividends per share (Unadj.) Rs2.500-  
Dividend yield (eoy) %0.60-  
Book value per share (Unadj.) Rs214.743.9 489.4%  
Shares outstanding (eoy) m282.1743.25 652.4%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.10.4 293.1%   
Avg P/E ratio x15.06.4 235.0%  
P/CF ratio (eoy) x9.84.4 222.4%  
Price / Book Value ratio x1.90.7 271.6%  
Dividend payout %9.10-   
Avg Mkt Cap Rs m116,7751,346 8,674.2%   
No. of employees `000NANA-   
Total wages/salary Rs m22,548369 6,118.5%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m106,4103,595 2,959.9%  
Other income Rs m1,5966 25,293.5%   
Total revenues Rs m108,0063,601 2,999.1%   
Gross profit Rs m17,310461 3,751.4%  
Depreciation Rs m4,17296 4,355.9%   
Interest Rs m3,77389 4,233.8%   
Profit before tax Rs m10,961283 3,875.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,20173 4,407.4%   
Profit after tax Rs m7,760210 3,691.6%  
Gross profit margin %16.312.8 126.7%  
Effective tax rate %29.225.7 113.7%   
Net profit margin %7.35.8 124.7%  
BALANCE SHEET DATA
Current assets Rs m68,0362,226 3,056.4%   
Current liabilities Rs m41,2601,401 2,946.0%   
Net working cap to sales %25.223.0 109.6%  
Current ratio x1.61.6 103.7%  
Inventory Days Days66 95.1%  
Debtors Days Days8394 87.7%  
Net fixed assets Rs m64,2551,476 4,353.0%   
Share capital Rs m282432 65.2%   
"Free" reserves Rs m60,2861,464 4,117.0%   
Net worth Rs m60,5681,897 3,193.2%   
Long term debt Rs m40,430318 12,702.6%   
Total assets Rs m132,2913,702 3,573.4%  
Interest coverage x3.94.2 93.6%   
Debt to equity ratio x0.70.2 397.8%  
Sales to assets ratio x0.81.0 82.8%   
Return on assets %8.78.1 107.8%  
Return on equity %12.811.1 115.6%  
Return on capital %14.616.8 86.9%  
Exports to sales %044.0 0.0%   
Imports to sales %09.2 0.0%   
Exports (fob) Rs mNA1,581 0.0%   
Imports (cif) Rs mNA332 0.0%   
Fx inflow Rs m47,7371,581 3,018.8%   
Fx outflow Rs m18,881397 4,755.7%   
Net fx Rs m28,8561,184 2,436.5%   
CASH FLOW
From Operations Rs m13,924310 4,491.4%  
From Investments Rs m-7,835-125 6,259.6%  
From Financial Activity Rs m-4,447-181 2,461.5%  
Net Cashflow Rs m1,7404 41,427.9%  

Share Holding

Indian Promoters % 46.6 43.8 106.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 36.6 0.9 4,300.0%  
FIIs % 26.8 0.2 16,762.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.4 56.2 94.9%  
Shareholders   275,801 40,512 680.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GLENMARK PHARMA With:   JUBILANT PHARMOVA   GRANULES INDIA  BH.IMMUN&BIO  MANGALAM DRUGS  GLAND PHARMA  



Today's Market

Sensex Ends 66 Points Lower; Bajaj Finance and Bajaj Finserv Among Top Nifty Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Related Views on News

GLENMARK PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 132.5% (Quarterly Result Update)

Sep 1, 2020 | Updated on Sep 1, 2020

For the quarter ended June 2020, GLENMARK PHARMA has posted a net profit of Rs 3 bn (up 132.5% YoY). Sales on the other hand came in at Rs 23 bn (up 0.9% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

GLENMARK PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 64.0% (Quarterly Result Update)

Feb 19, 2020 | Updated on Feb 19, 2020

For the quarter ended December 2019, GLENMARK PHARMA has posted a net profit of Rs 2 bn (up 64.0% YoY). Sales on the other hand came in at Rs 27 bn (up 7.1% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

GLENMARK PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Sep 5, 2019 | Updated on Sep 5, 2019

Here's an analysis of the annual report of GLENMARK PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of GLENMARK PHARMA. Also includes updates on the valuation of GLENMARK PHARMA.

GLENMARK PHARMA Announces Quarterly Results (1QFY20); Net Profit Down 53.1% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, GLENMARK PHARMA has posted a net profit of Rs 1 bn (down 53.1% YoY). Sales on the other hand came in at Rs 23 bn (up 7.3% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

GLENMARK PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 64.0% (Quarterly Result Update)

Feb 19, 2020 | Updated on Feb 19, 2020

For the quarter ended December 2019, GLENMARK PHARMA has posted a net profit of Rs 2 bn (up 64.0% YoY). Sales on the other hand came in at Rs 27 bn (up 7.1% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

More Views on News

Most Popular

Make Startup Profits from Bluechip Stocks(Profit Hunter)

Jul 21, 2021

A 166-bagger stock can deliver even more gains in this decade.

These Are the Best Stocks to Own(Fast Profits Daily)

Jul 22, 2021

Find out what I think are the best kind on stocks to own in the market.

Cash the Crash in Gas Prices(Fast Profits Daily)

Jul 21, 2021

Get ready to profit from the coming crash in the price of natural gas.

Electric 2-Wheelers: The Megatrend has Begun(Profit Hunter)

Jul 20, 2021

The shift to electric 2-wheelers will be faster than expected.

A Trading Hack to Multiply Profits(Fast Profits Daily)

Jul 23, 2021

Use this trading hack and get a big boost in your trading profits.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GLENMARK PHARMA SHARE PRICE


Jul 30, 2021 (Close)

TRACK GLENMARK PHARMA

  • Track your investment in GLENMARK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GLENMARK PHARMA

GLENMARK PHARMA 5-YR ANALYSIS

COMPARE GLENMARK PHARMA WITH

MARKET STATS